Throat Cancer Market Research Report- Forecast to 2027

Throat Cancer Market Information, by Types (Pharyngeal Cancer and Laryngeal Cancer), Treatments (Surgery, Radiation Therapy, Chemotherapy, Others) - Forecast to 2027

ID: MRFR/Pharma/1260-HCR | February 2021 | Region: Global | 80 pages

Throat Cancer Market Synopsis:


Market Scenario:
The Throat Cancer Market is one of the fastest growing markets. Cancer is a class of disease in which unusual cells duplicate and partition wildly in the body. These abnormal cells form threatening developments called tumors. Throat cancer refers to tumor of the voice box, the vocal cords, and different parts of the throat, for example, the tonsils and the oropharynx. The major factor that drives the throat cancer market is growing aging population. Throat Canceris Market expected to grow at the rate of about XX% from 2016 to 2022.

Throat Cancer Market, by Types



Intended Audience



  • Pharmaceutical manufacturers & Suppliers

  • Throat cancer drugs manufacturers & Suppliers

  • Pharmaceutical and biotechnology companies

  • Hospitals and oncology research centers

  • Academic research institutes

  • Government research institutes


Key Finding



  • The throat cancer global market is expected to reach $XX million by 2022.

  • Radiation therapy holds the largest share of XX% of the throat cancer market.

  • North America holds the largest market share of XX% of throat cancer market and is expected to reach $XX billion by the end of forecast period.

  • Asia Pacific is expected to be the fastest growing market at a CAGR of XX%



Segments:
Throat Cancer Market has been segmented on the basis of types which comprise of pharyngeal cancer and laryngeal cancer. On the basis of treatments types the market is segmented into surgery, radiation therapy, chemotherapy and others.

Regional Analysis of Throat Cancer Market:                   
Globally North America is the largest market for throat cancer. The North American market for throat cancer is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Europe is the second-largest market for throat cancer which is expected to grow at a CAGR of XX%. Asia pacific region is expected to be fastest growing region in throat cancer market.


Key Players for Throat Cancer Market:
Some of the key players in throat cancer market are: Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Engeneic Ltd, F. Hoffmann-la Roche AG, Merck & Co., Inc., Novartis, Pfizer Inc., Teva Pharmaceutical Industries Ltd and Others.                      


The report for Throat Cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the throat cancer market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected throat cancer market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions


Study objectives of the Throat Cancer Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7years of the various segments and sub-segments of the throat cancer market

  • To provide insights about factors affecting the throat cancer market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the throat cancer market segments and sub-segments with respect to the main geography and various regions globally.

  • To provide regional level analysis of the market with respect to the current market size and future prospective

  • To provide regional level analysis of the market for segments by types, by treatment typeand its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the throat cancer market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the throat cancer market. 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatments,
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Amgen Inc., Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Engeneic Ltd, F. Hoffmann-la Roche AG, Merck & Co., Inc., Novartis, Pfizer Inc., Teva Pharmaceutical Industries Ltd and Others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers   Growing aging population


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


The outlook of throat cancer market looks very promising.

Rising prevalence of throat cancer and the emergence of new drugs and therapies for the treatment are the major tailwinds pushing the growth of the global throat cancer market.

North America holds the largest share in the global throat cancer market, followed by Europe and the Asia Pacific, respectively.

Bristol-Myers Squibb, Amgen Inc., Celgene Corporation, Engeneic Ltd, Eli Lilly and Company, F. Hoffmann-la Roche AG, Novartis, Merck & Co., Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd., are some of the major players operating in the throat cancer market.

Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global throat cancer market adopt to gain a larger competitive advantage.

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Throat cancer Market, by Types

5.1 Introduction

5.1.1 Pharyngeal cancer

5.1.2 Laryngeal cancer

6 Global Throat cancer Market, by Treatments

6.1 Introduction

6.1.1 Surgery

6.1.2 Radiation therapy

6.1.3 Chemotherapy

6.1.4 Others

7 Global Throat cancer Market, by regions

7.1 Introduction

7.1.1 North America

7.1.1.1 US

7.1.1.2 Canada

7.1.2 Europe

7.1.2.1 Germany

7.1.2.2 France

7.1.2.3 UK

7.1.2.4 Italy

7.1.2.5 Spain

7.1.2.5 Rest of Europe

7.1.3 Asia Pacific

7.1.3.1 Japan

7.1.3.2 China

7.1.3.3 India

7.1.3.4 South Korea

7.1.3.5 Rest of Asia Pacific

7.1.4 Middle East & Africa

8 Company Landscape

8.1 Introduction

8.1.1 Mergers Acquisitions

8.1.2 Collaborations

8.1.3 Release/New Product Launches

9 Company Profile

9.1 Merck &Co.Inc.

9.1.1 Company Overview

9.1.2 Product/Business Segment Overview

9.1.3 Financials

9.1.4 Key Developments

9.2 Bristol-Myers Squibb

9.2.1 Overview

9.2.2 Product/Business Segment Overview

9.2.3 Financials

9.2.4 Key Developments

9.3 Pfizer Inc.

9.3.1 Overview

9.3.2 Product/Business Segment Overview

9.3.3 Financials

9.3.4 Key Developments

9.4 Eli Lilly and Company

9.4.1 Overview

9.4.2 Product/Business Segment Overview

9.4.3 Financials

9.4.4 Key Developments

9.5 F. Hoffmann-la Roche AG

9.5.1 Overview

9.5.2 Product/Business Segment Overview

9.5.3 Financials

9.5.4 Key Developments

10 Appendix